The aim of this study is to test the analgesic efficacy of etoricoxib (90 mg or 120 mg qd.
perioperatively) for post-operative pain relief.
The primary endpoint is as follows:
- does preoperative etoricoxib reduce the post-operative opioid utilization in patients
undergoing elective tonsillectomy under general anaesthesia (i.e. the post-operative
opioid-sparing effect of etoricoxib in humans).
The secondary endpoints are as follows:
- does the etoricoxib medication have an impact on PONV or activities of daily
- does the etoricoxib medication influence the blood loss during surgery or the incidence
of postoperative bleeding
- does the etoricoxib medication influence the operation time. In addition, adverse
effects of etoricoxib will be documented.